Invitae’s approach combines high-quality, low-cost genetic testing with Patient Insights Networks: online, interactive platforms for collecting, curating, coordinating, and delivering patient data.
By working with Invitae, biopharma partners
Remove barriers to testing, allowing patients to receive an accurate diagnosis quicker
Inform patients and clinicians of clinical trial and treatment opportunities
Confirm positive diagnoses and suspected cases with genetic testing
Understand the natural history of disease using patient-reported outcomes and clinical records
Build engaged patient communities
Genetic testing with Invitae
Invitae offers one of the broadest test menus, including panel testing for more than 1,500 genes and the option to order an exome (spanning approximately 20,000 genes).
Explore Invitae’s tests
Patient Insights Networks (PINs)
Patient Insights Networks help researchers and drug developers find better treatments, faster. Patients can contribute data about their experience with a disease and receive information about the latest research and clinical trial opportunities.
PINs identify patients who could benefit from genetic testing as well as patients who already have a genetic diagnosis and want to join a clinical trial or find new treatments. Read more about our launched PINs.
Selected Invitae commercial partners include: